GRAFTA Nanotech Corp.GFTA.V
Key ratios
FCF / Sales
-2220.8%TTM
2025
-637.7%
Net margin
6668.9%TTM
2025
2604.1%
ROA
-12.7%2025
ROE
135.9%2025
Recent news
GRAFTA Nanotech Corp. Announces Grant of Stock Options
GRAFTA Nanotech Corp. Engages Atrium Research to Provide Research Coverage
Track GFTA.V in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer